Patents by Inventor Ehud Ziv

Ehud Ziv has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
    Patent number: 8575307
    Abstract: The present invention provides peptides and peptide analogs capable of inhibiting the activity of protein kinase C. The invention discloses use of such peptides and analogs for preparation of pharmaceutical compositions and methods for prevention, delay, suppression or treatment of type 2 diabetes using such compositions.
    Type: Grant
    Filed: June 28, 2006
    Date of Patent: November 5, 2013
    Assignee: Hadasit Medical Research Services & Development Ltd.
    Inventors: Eleazar Shafrir, Ehud Ziv, Hadas Reuveni, Masha Niv
  • Protein Kinase C Inhibitors for Prevention of Insulin Resistance and Type 2 Diabetes
    Publication number: 20100216701
    Abstract: The present invention provides peptides and peptide analogs capable of inhibiting the activity of protein kinase C. The invention discloses use of such peptides and analogs for preparation of pharmaceutical compositions and methods for prevention, delay, suppression or treatment of type 2 diabetes using such compositions.
    Type: Application
    Filed: June 28, 2006
    Publication date: August 26, 2010
    Applicant: Hadasit Medical Research Services & Development Ltd.
    Inventors: Eleazar Shafrir, Ehud Ziv, Hadas Reuveni, Masha Niv
  • Pharmaceutical compositions containing insulin
    Patent number: 4579730
    Abstract: The invention provides a pharmaceutical composition for the oral administration of insulin comprising insulin, a bile acid or alkali metal salt thereof, the bile acid being selected from the group consisting of cholic acid, chenodeoxycholic acid, taurocholic acid, taurochenodeoxycholic acid, glycocholic acid, glycochenocholic acid, 3.beta.-hydroxy-12-ketocholic acid, 12.alpha.-3.beta.-dihydrocholic acid, and ursodesoxycholic acid, and a protease inhibitor, the composition being provided with an enterocoating to assure passage through the stomach and release in the intestine.
    Type: Grant
    Filed: May 9, 1984
    Date of Patent: April 1, 1986
    Assignee: Hadassah Medical Organization
    Inventors: Miriam Kidron, Ehud Ziv, Hanoch Bar-On, Amiram Eldor